Field Fisher Waterhouse LLP announces today the appointment of intellectual property partner Mark Hodgson. Mark, one of the country's leading patent litigators, joins from Howrey where he was managing partner of the firm's London office.
Mark specialises in advising pharmaceutical, medical device and biotechnology companies on intellectual property, regulatory, product liability and parallel import matters. He represents clients before the UK courts as well as managing multi-jurisdictional litigation and has advised on some of the leading patent cases of recent years including Court of Appeal case Eli Lilly v Human Genome Sciences and House of Lords case Angiotech v Conor Medsystems. Mark is recognised as a leader in his field by both Legal 500 and Chambers UK.
Mark's appointment is part of Fieldfisher's new strategy, unveiled last year, which sees the firm focus on building its IP & Technology, Corporate and Regulatory practices. The firm has a strong European IP practice which totals 23 dedicated IP partners and over 35 other lawyers across four countries. The appointment will build on the patent litigation side of the practice as well as the firms cross-practice life sciences capability.
Nick Rose, partner and head of the IP & Technology Dispute Resolution practice at Fieldfisher, said: "We are committed to investing in IP both in the UK and across Europe as part of the firm's focus on companies that are highly regulated and those with business models driven by IP and technology. Mark will be a significant addition to the team, enabling us to expand our patent litigation capability to match our expertise in other areas of IP such as trade marks."
For further press information, please contact:
Louise Eckersley, PR Manager, Field Fisher Waterhouse LLP on +44 (0)20 7861 4120.
Sign up to our email digest